PYC Physiomics Plc

TIDMPYC

RNS Number : 4234Q

Physiomics PLC

18 October 2023

18 October 2023

Physiomics plc

("Physiomics" or "the Company")

Notice of AGM

Physiomics plc (AIM: PYC), the oncology consultancy using mathematical models to support the development of cancer treatment regimens and personalised medicine solutions, is pleased to provide notice of the Company's Annual General Meeting ("AGM").

The AGM will be held at 10.30 a.m. on 21 November 2023 at the Company's new registered office, Bee House, 140 Eastern Avenue, Milton Park, Oxfordshire, OX14 4SB.

Shareholders will shortly be sent either printed copies of the Notice of AGM and accompanying materials or a letter notifying them that they are available on the Company's website, depending on the preferences they have expressed to the Company's registrar.

A copy of the Notice of AGM, containing further details of the resolutions, as well as a copy of the Company's Annual Report and Accounts will be made available today on the Company's website at www.physiomics.co.uk/investors/reports-prospectus/ .

Enquiries:

Physiomics plc

Dr Jim Millen, CEO

+44 (0)1865 784 980

Hybridan LLP (Broker)

Claire Louise Noyce

+44 (0) 203 764 2341

Strand Hanson Ltd (NOMAD)

James Dance & James Bellman

+44 (0)20 7409 3494

Notes to Editor

About Physiomics

Physiomics plc combines cutting edge PKPD and QSP modelling techniques with cancer biology expertise, to help biotech and pharma companies streamline their drug development journeys.

Our approach is to derive insight from all relevant data in order to de-risk decision making and optimise design of pre-clinical and clinical studies.

Through use of bespoke models and our proprietary Virtual Tumour technology, the Physiomics team has informed the development of over 100 commercial projects, over 50 targets and 75 drugs. Clients include Merck KGaA, Astellas, Bicycle Therapeutics, Numab Therapeutics & CRUK.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NOAGZMMGDNLGFZM

(END) Dow Jones Newswires

October 18, 2023 02:00 ET (06:00 GMT)

Physiomics (LSE:PYC)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

Physiomics (LSE:PYC)
Historical Stock Chart
Von Nov 2023 bis Nov 2024